{
  "ptid_time": "072_S_4462_2012-02-02",
  "img_path": "/data/qiuhui/data/adni/images/072_S_4462/2012-02-02/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 61,748 mm³, 60.3% above the reference mean. With a Z-score of 1.44 (92.6th percentile), this represents mild enlargement; hippocampal volume measures 7,008 mm³, 7.3% below the reference mean. With a Z-score of -0.71 (23.8th percentile), this represents normal volume ; whole brain volume measures 1,138,910 mm³, 5.5% above the reference mean. With a Z-score of 0.72 (76.3th percentile), this represents normal volume ; entorhinal cortex volume measures 2,622 mm³, 36.1% below the reference mean. With a Z-score of -2.45 (0.7th percentile), this represents significant atrophy; fusiform gyrus volume measures 18,041 mm³, 4.2% below the reference mean. With a Z-score of -0.36 (35.9th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,729 mm³, 6.5% above the reference mean. With a Z-score of 0.59 (72.1th percentile), this represents normal volume . ",
  "text_data": "Age is 71.3 years. Gender is Male. Education: 18 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Respiratory; Musculoskeletal; Endocrine-Metabolic; Gastrointestinal; Hematopoietic-Lymphatic; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Major Surgical Procedures. MMSE: 30.0. MoCA: 22.0. Logical Memory: 5.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.42 SUVR (significant elevated); Amyloid beta: 721.60 pg/mL (normal ); Total tau: 219.10 pg/mL (normal ); Phosphorylated tau: 21.12 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant atrophy in the entorhinal cortex (Z-score -2.45, 0.7th percentile), which is a key early marker of Alzheimer's pathology, alongside mild ventricular enlargement. Despite normal hippocampal volume, the entorhinal atrophy and elevated AV45 (amyloid PET) suggest amyloid deposition. The MoCA score of 22 indicates cognitive impairment, while MMSE (30) is less sensitive. Normal CSF biomarkers (Aβ, T-tau, P-tau) are atypical for AD but may reflect early stages or measurement variability.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, early neurodegenerative changes).  \n\n**Confidence:** **Medium** (due to conflicting biomarkers—normal CSF but elevated AV45—and preserved hippocampal volume despite entorhinal atrophy).",
  "timestamp": "2025-07-26T09:22:29.704882"
}